Yeah this is one of the biggest reasons to be bullish.They have been doing a few CR's over the last few years. Whilst not a bad thing to see in and of itself, it shows that they struggle to raise big money in one swoop. A look on their top 20 holders also does not show any large biotech/healthcare funds like BVF or even Regal -- granted the share price has been so bad for so long it is not surprising. It is good to see Dr Packham in there though. That said Taylor Collinson and Argonaut are obviously starting do brokerage research which means at least some people are sitting up to take notice.
Having more money at this stage will give them more leverage in negotiation they have (assuming +ve Phase II results) as well as more flexibility in creating a commercialisation strategy.
That said due to SAS, patent position and how its competitors are positioned I'll be turning my position from Not Held to Held by the end of the day.
They have been doing a few CR's over the last few years. Whilst...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.020(4.65%) |
Mkt cap ! $247.7M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 46.3¢ | 42.5¢ | $1.449M | 3.222M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 143129 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 73280 | 3 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |